We are live on ! Find out more
RFC

Russell Frank Company Portfolio holdings

AUM $56.9B
1-Year Est. Return 2.13%
This Fund
S&P 500
This Quarter Est. Return
+7.02%
1 Year Est. Return
+2.13%
3 Year Est. Return
+42.95%
5 Year Est. Return
10 Year Est. Return
AUM
$56.9B
AUM Growth
+$2.28B
Cap. Flow
-$893M
Cap. Flow %
-1.57%
Top 10 Hldgs %
9.98%
Holding
3,594
New
174
Increased
1,805
Reduced
1,400
Closed
130

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$94.4M
2
ORCL icon
Oracle
ORCL
+$72.1M
3
TWX
Time Warner Inc
TWX
+$57.8M
4
GM icon
General Motors
GM
+$51.1M
5
PVH icon
PVH
PVH
+$44M

Sector Composition

Rank Sector Weight
1 Financials 16.55%
2 Technology 12.88%
3 Industrials 11.19%
4 Healthcare 11.1%
5 Consumer Discretionary 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RUE
3351
DELISTED
RUE21 INC COM STK (DE)
RUE
$3K ﹤0.01%
84
-15
-15% -$621
QADA
3352
DELISTED
QAD Inc.
QADA
$3K ﹤0.01%
211
+173
+455% +$2.21K
DYN.WS
3353
DELISTED
Dynegy Inc,
DYN.WS
$3K ﹤0.01%
2,191
AMBA icon
3354
Ambarella
AMBA
$3.81B
$2K ﹤0.01%
99
-41,902
-100% -$713K
ASRT
3355
DELISTED
Assertio
ASRT
$2K ﹤0.01%
5
-1
-17% -$408
BFAM icon
3356
Bright Horizons
BFAM
$3.86B
$2K ﹤0.01%
+64
New +$2.3K
HWKN icon
3357
Hawkins
HWKN
$2.71B
$2K ﹤0.01%
100
-18
-15% -$358
PETS icon
3358
PetMed Express
PETS
$42.3M
$2K ﹤0.01%
112
-37,775
-100% -$589K
TURN
3359
DELISTED
180 Degree Capital
TURN
$2K ﹤0.01%
243
-69
-22% -$639
ATRI
3360
DELISTED
Atrion Corp
ATRI
$2K ﹤0.01%
8
-2
-20% -$487
CGRN
3361
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$2K ﹤0.01%
8
-1
-11% -$249
AMPE
3362
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$2K ﹤0.01%
1
ZIXI
3363
DELISTED
Zix Corporation
ZIXI
$2K ﹤0.01%
337
-58
-15% -$260
GNMK
3364
DELISTED
GenMark Diagnostics, Inc
GNMK
$2K ﹤0.01%
+155
New +$1.66K
SGYP
3365
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$2K ﹤0.01%
435
+163
+60% +$731
PRKR
3366
DELISTED
Parkervision Inc
PRKR
$2K ﹤0.01%
47
-11,853
-100% -$475K
GNCMA
3367
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
$2K ﹤0.01%
168
-69
-29% -$634
LMOS
3368
DELISTED
Lumos Networks Corp
LMOS
$2K ﹤0.01%
79
-14
-15% -$251
MACK
3369
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$2K ﹤0.01%
62
+49
+377% +$1.71K
MFRM
3370
DELISTED
MATTRESS FIRM HLDG CORP COM STK (DE)
MFRM
$2K ﹤0.01%
58
-55,110
-100% -$2.19M
RVLT
3371
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
$2K ﹤0.01%
+69
New +$2.5K
STSI
3372
DELISTED
STAR SCIENTIFIC INC
STSI
$2K ﹤0.01%
892
-41
-4% -$78
GWAY
3373
DELISTED
GREENWAY MED TECHNOLOGIES INC CPM STK (DE)
GWAY
$2K ﹤0.01%
77
+25
+48% +$340
DTSI
3374
DELISTED
DTS, Inc.
DTSI
$2K ﹤0.01%
96
-17
-15% -$371
WLH
3375
DELISTED
WILLIAM LYON HOMES
WLH
$2K ﹤0.01%
+74
New +$1.64K

Similar funds

Russell Frank Company's Q3 2013 Portfolio in Review

As of Q3 2013, Russell Frank Company held 3,594 positions worth $56.9B, up 4.2% from $54.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Russell Frank Company's Q3 2013 filing shows 174 new, 1,805 increased, 1,400 reduced and 130 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 1,013,242 shares worth $33.9M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $134M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Industrials.

  • Russell Frank Company's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 1,013,242 shares worth $33.9M.
  • Russell Frank Company added most to Boeing in Q3 2013, an estimated $94.4M increase.
  • Russell Frank Company's biggest Q3 2013 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $134M.
  • Russell Frank Company fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q3 2013, selling an estimated $125M.
  • Russell Frank Company's ten largest holdings make up 10% of its $56.9B portfolio in Q3 2013.
  • Russell Frank Company opened 174 new positions and closed 130 in Q3 2013.
  • Russell Frank Company's portfolio value rose 4.2% quarter-over-quarter to $56.9B.

Based on Russell Frank Company's 13F filing for Q3 2013, filed 29 Oct 2013.